Clinical Trials
3 trialsNCT05383898 2024-10-15
Study to Evaluate D-1553 in Subjects With Lung Cancer
InventisBio Co., Ltd
Phase 1/2 Completed
NCT03562871 2022-04-21
IO102 With Pembrolizumab, With or Without Chemotherapy, as First-line Treatment of Metastatic NSCLC
IO Biotech
Phase 1/2 Completed
NCT00072618 2011-10-20
Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients
Astellas Pharma Inc
Phase 1/2 Completed